Clinical Trial Update: A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma. [Phase 2]

View source ↗

Summary

Phase II study assessing neoadjuvant pembrolizumab in patients with pT3b-T4a/b cN0M0 melanoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Melanoma (Skin Cancer) | Phase 2 | Status: RECRUITING